Canada enacts new regulations before US drug import rule - Al Jazeera English | Canada News Media
Connect with us

Business

Canada enacts new regulations before US drug import rule – Al Jazeera English

Published

 on


New Trump administration rule allowing US pharmacists and wholesalers to import prescription drugs in bulk from Canada comes into effect Monday.

The Canadian government has announced new measures it said are designed to prevent drug shortages, only days before a new Trump administration rule would allow pharmacists and wholesalers in the United States to import drugs from Canada.

In a statement on Saturday, Canada said that as of Friday certain drugs intended for the Canadian market were barred from being distributed outside the country “if that sale would cause or worsen a drug shortage”.

Companies also must provide the government with information about existing or potential shortages when requested. Those requests must be answered within 24 hours if there is a serious or imminent health risk, the statement said.

“Our healthcare system is a symbol of our national identity and we are committed to defending it. The actions we are taking today will help protect Canadians’ access to the medication they rely on,” Canada’s Health Minister Patty Hadju said.

US President Donald Trump announced plans late last year to allow US states and Indigenous governments to set up programmes to import prescription drugs from Canada as part of an effort to lower what are often exorbitantly high costs for American consumers.

That new regulation, known as the Importation of Prescription Drugs rule, comes into effect on Monday.

Under the new regulations, Indigenous governments, pharmacists and wholesalers will be allowed to propose drug importation proposals to the US Food and Drug Administrations (FDA).

Importers must demonstrate how those proposals respect US health and safety regulations and help reduce costs, the rule states.

“The purpose … is to achieve a significant reduction in the cost of covered products to the American consumer while posing no additional risk to the public’s health and safety,” according to the new rule.

Ottawa has said importing drugs from Canada would not help address high costs in the US since the Canadian market of prescription drugs represents only two percent of global sales.

The cost of prescription drugs in the United States is often exorbitantly high [File: George Frey/Reuters]

But several US states, including Florida and Vermont, have expressed an interest in importing drugs from Canada, the head of the US Department of Health and Human Services (HHS), Alex Azar, said last year, Reuters News Agency reported.

On November 23, Republican Florida Governor Ron DeSantis announced that he had submitted a proposal to the HHS to import medication from Canada.

The state will begin by importing drugs to help people with chronic health conditions including asthma, diabetes and HIV/AIDS, DeSantis said in a statement.

“For far too long, Floridians have been paying exorbitant prices for prescription drugs,” he said. “Today, we take another step towards lowering those prices.”

US pharmaceutical companies have raised opposition, however, and earlier this week, three industry groups filed a lawsuit against the new regulation, alleging it “disregards key protections … designed to ensure patient safety”.

“It is alarming that the administration chose to pursue a policy that threatens public health at the same time that we are fighting a global pandemic,” James Stansel, executive vice president of Pharmaceutical Research and Manufacturers of America, said in a statement.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Canada Goose to get into eyewear through deal with Marchon

Published

 on

 

TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.

The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.

The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.

Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.

Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.

Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

TD CEO to retire next year, takes responsibility for money laundering failures

Published

 on

 

TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.

Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.

The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.

As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.

TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.

TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version